RE:RE:It Was Just A Typo"if it was he who responded"
tim mccarthy is on the corporate website as the IR contact with his phone number listed. tim didn't "respond", i called him at the listed number, he answered the phone, and he said it was a typo.
just got this response from jon patton: Jon Patton
From:jpatton@oncolytics.ca
To:Dave
Thu, Jun 27 at 4:03 PM
Hi Dave,
This is an inadvertent holdover from a previous S-8 and utterly inconsequential. Dr. Thompson holds no rights, authority or power of attorney in relation to Oncolytics Biotech nor does he have any involvement with the company. We have confirmed with US counsel that no action is required, and we consider this matter closed.
Best,
Jon
Confidentiality Notice: This message is intended only for the use of the individual or entity to which it is addressed and may contain information that is privileged, confidential and exempt from disclosure under applicable law. Any other distribution, copying or disclosure is strictly prohibited. If you have received this message in error, please notify the sender immediately by return e-mail or by telephone at (403-670-7377) (Canada) and electronically delete this message without making a copy.
and this is response from counsel this morning:
Bennett, Michael J.
From:
mbennett@mccarthy.ca
To:
Dave
Thu, Jun 27 at 9:34 AM
Entirely understandable that you may have formed that view; however, our opinion which we were required to provide in connection with the filing of the Form S-8 with the SEC does not speak to the Form S-8 filing in any way, including as to its accuracy or completeness. Rather, our opinion relates solely to the status of the common shares issuable upon exercise of options and vesting of restricted share awards and fully-paid and non-assessable shares of the company under and in accordance with Alberta corporate law. It is not necessary for us to review the Form S-8 in order to render an opinion to that effect.
From: Dave
Sent: Wednesday, June 26, 2024 9:02 PM
To: Bennett, Michael J. <MBENNETT@mccarthy.ca>
Subject: Re: [EXT] Fw: oncolytics biotech
Mr. Bennett,
Thank you for your reponse. However, as noted in the information below, your firm provided the consent and opinion in connection with the preparation and filing with the United States SEC under the United States Securities Act of 1933, as amended, of Oncolytics Registration Statement on Form S-8.
That is one of the reasons I was reaching out to your firm for an explanation regarding the appointment of Brad Thompson as the attorney-in-fact for the 9 officers and directors of Oncolytics who signed the document.
Since your firm examined all of the records, documents, agreements etc. associated with the Registration Statement, it seemed that you would be in a position to comment.